Heather Prichard
Chief Operating Officer bei HUMACYTE, INC.
Vermögen: 200 800 $ am 31.03.2024
Profil
Heather Prichard is currently the Chief Operating Officer at Humacyte Global, Inc. since 2019 and at Humacyte, Inc. since 2021.
She holds a doctorate degree from Duke University and an undergraduate degree from Georgia Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HUMACYTE, INC.
0,06% | 11.12.2023 | 64 566 ( 0,06% ) | 200 800 $ | 31.03.2024 |
Aktive Positionen von Heather Prichard
| Unternehmen | Position | Beginn |
|---|---|---|
| HUMACYTE, INC. | Chief Operating Officer | 26.08.2021 |
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Chief Operating Officer | 01.03.2019 |
Ausbildung von Heather Prichard
| Duke University | Doctorate Degree |
| Georgia Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
